0.96
price up icon4.03%   0.0372
 
loading
Io Biotech Inc stock is traded at $0.96, with a volume of 213.60K. It is up +4.03% in the last 24 hours and down -17.95% over the past month. IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
See More
Previous Close:
$0.9228
Open:
$0.93
24h Volume:
213.60K
Relative Volume:
1.33
Market Cap:
$58.59M
Revenue:
-
Net Income/Loss:
$-86.08M
P/E Ratio:
-0.445
EPS:
-2.1574
Net Cash Flow:
$-72.06M
1W Performance:
+11.61%
1M Performance:
-17.95%
6M Performance:
-20.66%
1Y Performance:
-33.79%
1-Day Range:
Value
$0.85
$1.00
1-Week Range:
Value
$0.85
$1.00
52-Week Range:
Value
$0.66
$1.79

Io Biotech Inc Stock (IOBT) Company Profile

Name
Name
Io Biotech Inc
Name
Phone
(457) 070-2980
Name
Address
OLE MAALOES VEH 3, COPENHAGEN
Name
Employee
80
Name
Twitter
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
IOBT's Discussions on Twitter

Compare IOBT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IOBT
Io Biotech Inc
0.96 58.59M 0 -86.08M -72.06M -2.1574
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Io Biotech Inc Stock (IOBT) Latest News

pulisher
Apr 26, 2025

IO Biotech's Co-Founder Mads Hald Andersen Highlights Advances in Cancer Vaccine Research at 2025 AACR Annual Meeting - Nasdaq

Apr 26, 2025
pulisher
Apr 26, 2025

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 - The Globe and Mail

Apr 26, 2025
pulisher
Apr 25, 2025

IO Biotech unveils promising vaccine preclinical data By Investing.com - Investing.com India

Apr 25, 2025
pulisher
Apr 25, 2025

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170 - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting - The Manila Times

Apr 25, 2025
pulisher
Apr 25, 2025

New Cancer Vaccine Data Shows Powerful Immune Response in Multiple Tumors | IOBT Stock News - Stock Titan

Apr 25, 2025
pulisher
Apr 25, 2025

Short Sellers Gave Up on These 3 Names Recently - The Globe and Mail

Apr 25, 2025
pulisher
Apr 25, 2025

4 Cheap Stocks With Solid Fundamentals to Offset Market Uncertainty - The Globe and Mail

Apr 25, 2025
pulisher
Apr 25, 2025

Cotton Extending Strength to Friday Morning - The Globe and Mail

Apr 25, 2025
pulisher
Apr 24, 2025

Healthcare Services (HCSG) Receives a Hold from William Blair - The Globe and Mail

Apr 24, 2025
pulisher
Apr 24, 2025

3 Reasons AMTM is Risky and 1 Stock to Buy Instead - The Globe and Mail

Apr 24, 2025
pulisher
Apr 23, 2025

Nano One 2025 Annual General Meeting of Shareholders - The Globe and Mail

Apr 23, 2025
pulisher
Apr 23, 2025

Boeing doesn't expect the US trade war with China to slow its recovery - The Globe and Mail

Apr 23, 2025
pulisher
Apr 22, 2025

[WATCH] Trading Gaps: Spot Big Moves Before They Happen - The Globe and Mail

Apr 22, 2025
pulisher
Apr 22, 2025

Limbach (LMB): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail

Apr 22, 2025
pulisher
Apr 18, 2025

Pre-market Movers: OPTN, WINT, AKBA, GCTK... - RTTNews

Apr 18, 2025
pulisher
Apr 17, 2025

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - The Globe and Mail

Apr 17, 2025
pulisher
Apr 16, 2025

Viking Therapeutics Stock Pops But Struggles to Hold Gains - The Globe and Mail

Apr 16, 2025
pulisher
Apr 15, 2025

CrowdStrike Stock is a Buy as Cyberthreat Environment Expands - The Globe and Mail

Apr 15, 2025
pulisher
Apr 14, 2025

5 Top Psychedelic Stocks (2025) for Mental Health Investing - Securities.io

Apr 14, 2025
pulisher
Apr 12, 2025

We're A Little Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Rate - Yahoo Finance

Apr 12, 2025
pulisher
Apr 10, 2025

Metastatic Melanoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Apr 10, 2025
pulisher
Apr 10, 2025

Google (GOOGL) Offers U.S. Government Major Discounts as It Challenges Microsoft - The Globe and Mail

Apr 10, 2025
pulisher
Apr 10, 2025

Seeking High Dividend Yield? Earn 9.6% from This Energy Stock Now. - The Globe and Mail

Apr 10, 2025
pulisher
Apr 09, 2025

NESR to Participate in Water Tower Research Fireside Chat on April 10 at 11am ET - The Globe and Mail

Apr 09, 2025
pulisher
Apr 08, 2025

Financial Survey: Vistagen Therapeutics (NASDAQ:VTGN) versus IO Biotech (NASDAQ:IOBT) - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

WSP Global Inc. (TSE:WSP) Receives C$284.85 Consensus Target Price from Brokerages - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

Evergy, Inc. (NASDAQ:EVRG) Receives $69.08 Average Price Target from Brokerages - Defense World

Apr 08, 2025
pulisher
Apr 08, 2025

Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) PT at $19.11 - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

Ag Futures Markets Are Suffering a Severe Case of Tariff Indigestion. When Will They Rebound? - The Globe and Mail

Apr 07, 2025
pulisher
Apr 06, 2025

Prediction: This Artificial Intelligence (AI) Semiconductor Stock Could Start Soaring After April 16 - The Globe and Mail

Apr 06, 2025
pulisher
Apr 05, 2025

Q1 Earnings Forecast for IO Biotech Issued By HC Wainwright - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

Globus Medical acquires Nevro Corp. - Medical Buyer

Apr 05, 2025
pulisher
Apr 04, 2025

Is Nvidia Stock a Buy or Sell Below $100 as a Global Trade War Escalates? - The Globe and Mail

Apr 04, 2025
pulisher
Apr 02, 2025

IO Biotech (NASDAQ:IOBT) Given “Buy” Rating at HC Wainwright - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Fresh Quarter, Fresh Momentum? Markets Eye April 2nd Tariff Announcement - The Globe and Mail

Apr 01, 2025
pulisher
Mar 31, 2025

IO Biotech Inc. (IOBT) reports earnings - qz.com

Mar 31, 2025
pulisher
Mar 28, 2025

New PM2 Gene Discovery by Aurora Cannabis Enhances Disease Resistance - Securities.io

Mar 28, 2025
pulisher
Mar 28, 2025

Alcon acquires majority stake in Aurion Biotech - Healio

Mar 28, 2025
pulisher
Mar 27, 2025

IO Biotech secures over 400 million dkk in new capital - Dansk Industri

Mar 27, 2025
pulisher
Mar 26, 2025

IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting - The Manila Times

Mar 26, 2025
pulisher
Mar 25, 2025

IO Biotech Announces Acceptance Of Abstracts To Be Presented At The 2025 American Association For Cancer Research (AACR) Annual Meeting - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 25, 2025
pulisher
Mar 24, 2025

Palantir Insiders including PLTR CEO Dump Shares as Valuation Skyrockets 340% - The Globe and Mail

Mar 24, 2025
pulisher
Mar 21, 2025

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Globe and Mail

Mar 21, 2025
pulisher
Mar 20, 2025

Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 20, 2025
pulisher
Mar 19, 2025

TCEHY Earnings: Tencent Profits Leap on Gaming and Ads as Investors Wait on AI Returns - The Globe and Mail

Mar 19, 2025
pulisher
Mar 18, 2025

IO Biotech Named Among Fast Company's World's Most Innovative Companies of 2025 - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

IO Biotech Named Among Fast Company’s World’s Most Innovative Companies of 2025 - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Fast Company Names IO Biotech Top 10 Innovator for Cancer Vaccine Breakthrough - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

These 10 biotech companies are changing how we discover new drugs and treat complex diseases - Fast Company

Mar 18, 2025

Io Biotech Inc Stock (IOBT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Io Biotech Inc Stock (IOBT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Zocca Mai-Britt
Chief Executive Officer
Dec 23 '24
Buy
0.81
12,500
10,120
49,891
Sullivan Amy
Chief Financial Officer
Dec 23 '24
Buy
0.83
10,250
8,483
84,632
Smith Devin Whittemore
General Counsel
Dec 23 '24
Buy
0.81
12,000
9,720
16,938
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Cap:     |  Volume (24h):